Skip to main content

Table 1 Clinicopahtological characteristics of patients grouped according to GPS

From: The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma

Variable

GPS 0 (n = 81)

GPS 1 (n = 49)

GPS 2 (n = 20)

P-value

Age (years)

71 (43–91)

74 (54–86)

72 (51–79)

0.05

Sex (male/female)

57/23

33/16

16/4

0.57

HBsAg positive (%)

8(10)

4 (8.2)

5 (25)

0.12

HCVAb positive (%)

52 (65)

24 (49)

7 (35)

0.03

AST (IU/l)

50 (18–148)

58 (14–240)

113 (13–384)

<0.0001

ALT (IU/l)

39 (10–202)

39 (12–190)

78 (8–157)

0.02

Total serum bilirubin (mg/dl)

0.7 (0.3-1.9)

1 (0.3-6.1)

1.6 (0.3-8.3)

<0.0001

Albumin (g/dl)

3.9 (3.5-5)

3.2 (2.1-4.6)

3.2 (2.2-3.4)

<0.0001

CRP (mg/dl)

0.1 (0.1-0.8)

0.3 (0.1-2.9)

2.6 (1.1-18.8)

<0.0001

WBC (cells/mm3)

5300 (2500–14800)

5100 (1800–14900)

5800 (3900–12400)

0.13

Platelet count (104/mm3)

14.2 (2.9-29.5)

11.6 (1.8-42.1)

17.3 (8.7-44.3)

0.07

Prothrombin time (%)

85 (38–100)

78 (41–100)

77 (45–97)

0.02

α-fetoprotein (ng/ml)

17 (1.9-59597)

52 (2–138011)

144 (1.7-280600)

0.01

Child-Pugh grade (A/B/C)

78/2/0

22/25/2

6/10/4

<0.0001

CLIP score (0/1/2/3)

35/31/10/4

8/12/17/12

0/7/1/12

<0.0001

JIS score (0/1/2/3)

17/32/27/4

0/15/17/17

0/1/6/13

<0.0001

BCLC score (0/A/B/C,D)

16/41/19/4

1/24/14/10

0/6/2/12

<0.0001

Tumor stage (І,ІІ,ІІІ,ІV)

16/34/28/2

4/22/16/7

1/4/4/11

<0.0001

Maximal tumor diameter (mm)

28 (7–90)

37 (10–200)

50 (10–130)

0

Tumor number (solitary/multiple)

45/35

26/23

5/15

0.04

Vascular invasion (absent/present)

77/3

44/5

13/7

0

Extrahepatic metastasis (absent/present)

79/1

47/2

17/3

0.02

  1. Abbreviaions: HBsAg = hepatitis B surface antigen; HCVAb = hepatitis C antibody; AST = aspartate aminotransferase; ALT = alanine aminotransferase.
  2. CRP = C-reactive protein; WBC = white blood cell count; ICG = indocyanine green dye retention rate at 15 minutes; CLIP = Cancer of the Liver Italian Program.
  3. JIS = Japan Integrated Staging score; BCLC = Barcelona Clinic Liver Cancer; GPS = Glasgow Prognostic Score.